GlobeImmune
GlobeImmune, Inc. is a clinical-stage public biopharmaceutical company headquartered in Louisville, Colorado, that develops therapeutic vaccines to treat cancer and infectious diseases. As of August 2014, the company had no marketed products. GlobeImmune’s therapeutic vaccines are developed on the company’s Tarmogen immunotherapy platform. Tarmogens are made from genetically modified yeast that express one or more disease-associated antigens. Tarmogens activate T cells to specifically target and eliminate diseased cells with the same target antigen.
Source: Wikipedia · CC BY-SA 4.0
last observed
Activity Score
0
confidence 95 % · metrics-v1
Hiring Momentum 30d
—
not enough monitored evidence
Product Velocity
0
confidence 70 % · metrics-v1
AI Adoption
0
confidence 60 % · metrics-v1
Corporate Change Index
0
confidence 82 % · cci-v1
11 active sensors·11 observations·0 historical changes·0 structured events·historical coverage 100 %·observed since 2026-09-13
Compare GlobeImmune with peers on activity, hiring, product velocity, AI adoption, locations and events.
Compare companies